Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP25817.RAbHyOuzUb-nevr1VJ74qVkpM1PF1EgIm_wTd6U4XohVg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP25817.RAbHyOuzUb-nevr1VJ74qVkpM1PF1EgIm_wTd6U4XohVg130_assertion type Assertion NP25817.RAbHyOuzUb-nevr1VJ74qVkpM1PF1EgIm_wTd6U4XohVg130_head.
- NP25817.RAbHyOuzUb-nevr1VJ74qVkpM1PF1EgIm_wTd6U4XohVg130_assertion description "[A nonsynonymous variation in MRP2/ABCC2 is associated with neurological adverse drug reactions of carbamazepine in patients with epilepsy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP25817.RAbHyOuzUb-nevr1VJ74qVkpM1PF1EgIm_wTd6U4XohVg130_provenance.
- NP25817.RAbHyOuzUb-nevr1VJ74qVkpM1PF1EgIm_wTd6U4XohVg130_assertion evidence source_evidence_curated NP25817.RAbHyOuzUb-nevr1VJ74qVkpM1PF1EgIm_wTd6U4XohVg130_provenance.
- NP25817.RAbHyOuzUb-nevr1VJ74qVkpM1PF1EgIm_wTd6U4XohVg130_assertion SIO_000772 20216337 NP25817.RAbHyOuzUb-nevr1VJ74qVkpM1PF1EgIm_wTd6U4XohVg130_provenance.
- NP25817.RAbHyOuzUb-nevr1VJ74qVkpM1PF1EgIm_wTd6U4XohVg130_assertion wasDerivedFrom ctd_human-2016 NP25817.RAbHyOuzUb-nevr1VJ74qVkpM1PF1EgIm_wTd6U4XohVg130_provenance.
- NP25817.RAbHyOuzUb-nevr1VJ74qVkpM1PF1EgIm_wTd6U4XohVg130_assertion wasGeneratedBy ECO_0000218 NP25817.RAbHyOuzUb-nevr1VJ74qVkpM1PF1EgIm_wTd6U4XohVg130_provenance.